Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001288564 | SCV000512550 | likely benign | not provided | 2019-07-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000862742 | SCV001003290 | likely benign | Developmental and epileptic encephalopathy, 2; Angelman syndrome-like | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001288564 | SCV001475767 | likely benign | not provided | 2020-05-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002411288 | SCV002720988 | likely benign | Inborn genetic diseases | 2018-03-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |